Fiera Capital Corp reduced its position in CVS Health Corp (NYSE:CVS) by 4.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,675 shares of the pharmacy operator’s stock after selling 841 shares during the period. Fiera Capital Corp’s holdings in CVS Health Corp were worth $1,395,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of CVS. Integrated Wealth Management increased its stake in shares of CVS Health Corp by 3.8% in the third quarter. Integrated Wealth Management now owns 1,348 shares of the pharmacy operator’s stock worth $120,000 after buying an additional 49 shares during the last quarter. Gemmer Asset Management LLC increased its stake in shares of CVS Health Corp by 7.6% in the third quarter. Gemmer Asset Management LLC now owns 1,409 shares of the pharmacy operator’s stock worth $125,000 after buying an additional 100 shares during the last quarter. Klingman & Associates LLC increased its stake in shares of CVS Health Corp by 27.5% in the third quarter. Klingman & Associates LLC now owns 1,625 shares of the pharmacy operator’s stock worth $145,000 after buying an additional 350 shares during the last quarter. Elgethun Capital Management purchased a new stake in shares of CVS Health Corp during the fourth quarter worth about $133,000. Finally, Arcadia Investment Management Corp MI increased its stake in shares of CVS Health Corp by 5.9% in the third quarter. Arcadia Investment Management Corp MI now owns 1,700 shares of the pharmacy operator’s stock worth $151,000 after buying an additional 95 shares during the last quarter. 81.29% of the stock is owned by institutional investors and hedge funds.
CVS Health Corp (NYSE:CVS) traded down 0.19% during trading on Friday, hitting $79.28. 6,724,304 shares of the company traded hands. CVS Health Corp has a 52 week low of $69.30 and a 52 week high of $106.67. The company’s 50 day moving average is $78.91 and its 200-day moving average is $80.09. The stock has a market capitalization of $84.12 billion, a PE ratio of 16.15 and a beta of 0.85.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, May 1st. Investors of record on Friday, April 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date is Wednesday, April 19th. CVS Health Corp’s payout ratio is 40.65%.
A number of research analysts have weighed in on the stock. Leerink Swann set a $90.00 target price on shares of CVS Health Corp and gave the company a “buy” rating in a research note on Saturday, March 18th. Jefferies Group LLC set a $82.00 target price on shares of CVS Health Corp and gave the company a “hold” rating in a research note on Saturday, April 1st. Guggenheim reiterated a “buy” rating and issued a $90.00 target price on shares of CVS Health Corp in a research note on Wednesday, December 28th. Vetr cut shares of CVS Health Corp from a “buy” rating to a “hold” rating and set a $82.45 target price on the stock. in a research note on Thursday, February 16th. Finally, Atlantic Securities cut shares of CVS Health Corp from an “overweight” rating to a “neutral” rating and set a $84.00 target price on the stock. in a research note on Monday, February 6th. Seven equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. CVS Health Corp presently has a consensus rating of “Buy” and an average target price of $96.23.
In related news, EVP Eva C. Boratto sold 6,029 shares of the firm’s stock in a transaction dated Friday, March 17th. The stock was sold at an average price of $79.60, for a total transaction of $479,908.40. Following the completion of the sale, the executive vice president now directly owns 41,614 shares of the company’s stock, valued at approximately $3,312,474.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Troyen A. Brennan sold 23,849 shares of the firm’s stock in a transaction dated Tuesday, March 21st. The stock was sold at an average price of $78.73, for a total value of $1,877,631.77. Following the sale, the executive vice president now directly owns 94,309 shares of the company’s stock, valued at $7,424,947.57. The disclosure for this sale can be found here. Insiders have sold a total of 200,796 shares of company stock valued at $16,101,642 over the last three months. Corporate insiders own 0.58% of the company’s stock.
About CVS Health Corp
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
